Research Trial articles, blogs, webinars, videos, fact sheets, resources, etc.
What You Need To Know About Blood Tests For Cancer
Blood tests that aim to detect multiple types of cancer have recently been in the news. However, most of these tests are not FDA-approved as clinical trials testing their effectiveness are still ongoing.
Robert H. Vonderheide, MD, DPhil, FAACR, Elected as American Association for Cancer Research President-Elect for 2026-2027
Unlocking Cancer Interception
Since our founding in 2012, Basser has been steadfast in our commitment to BRCA mutation carriers and their families. Now we are doubling down with the creation of the Basser Cancer Interception Institute, which aims to dramatically disrupt the timeline of cancer treatment, intercepting disease when the very first abnormal BRCA1/2 cells develop.
Volunteering for Cancer Research: An Act of Love
Motivated by generations past, present, and future, two patients participating in the first-of-its-kind clinical trial are testing an experimental approach to stop cancer in its tracks at the earliest stages of development at the Basser Center.
WSJ: Researchers At Health Institutions Like Penn Medicine Are Testing Vaccines to Prevent Cancer
Researchers across the country are making progress toward vaccines that train healthy people’s immune systems to eliminate signs of cancer before it develops. Healthy BRCA mutation carriers are participating in a clinical trial.
Can We Prevent Cancer With a Shot?
Healthy volunteers who carry BRCA gene mutations are participating in a cancer vaccine clinical trial. If the study is successful, the work could eventually extend to more cancers or other risk factors, noted ACC director Dr. Vonderheide.
The Biology of ‘Precancer’: Stopping Cancer Before It Starts
As Dr. Susan Domchek leads a clinical trial for a cancer interception vaccine, the team seeks to understand “precancer”—the critical period after cells have started to grow abnormally but before they’ve developed into cancer.
Basser Center Board Member and Reporter Discusses Cancer Treatment
Basser executive director Susan Domchek, MD, explains how a class of drugs called PARP inhibitors can help treat cancers related to BRCA mutations to ABC7 news reporter Stacey Sager, who shared an update on her cancer journey.
Big-Time Athletes Swing for a Cure at Mid Penn Bank Celebrity Golf Classic
Money raised from the Mid Penn Bank Celebrity Golf Classic at Hershey Country Club will support cancer research at the Pennsylvania Breast Cancer Coalition and the Basser Center for BRCA at Penn Medicine.
A Shot in the Arm That Can Help Fight Cancer? How Vaccine Trials Are Showing Promise
Filko Prugo, a BRCA2 mutation carrier who is participating in the Basser Center's cancer prevention vaccine trial, shares why clinical trial participation is vital to progress research.